Apollo Health Ventures leverages venture building and early-stage investing to create and accelerate transformational companies focused on age-related healthcare, particularly neurodegenerative diseases and immune-mediated inflammatory conditions. They combine scientific expertise, operational support, and capital access to minimize risk and maximize value creation across Europe and the US.
Preferred startup development maturity for initial funding deployment.
Age-related healthcare, neurodegenerative diseases, immune-mediated inflammatory diseases, at-home therapy solutions, AI-powered drug discovery, antibody therapies, hematologic malignancies
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...